Clinical Trial Update: Evaluation of Rosacea-related Inflammatory Biochemical Markers in Adult Skin When Treated With Oracea® vs Placebo [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating inflammatory biochemical markers in adult skin for rosacea patients treated with Oracea versus placebo; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• ORACEA (Doxycycline)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 4 | Status: COMPLETED | Results posted: 2014-08-05